Hepatic encephalopathy;Hepatische enzephalopathie

Nervenarzt

Volumn 74, Issue 12, 2003, Pages 1078-1087

  Schellinger, P D ^a   Hartmann, M K ^a   Klingmann, Ch ^a   Meinck, H M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Ammonium; Disturbance in brain functions; Hepatic encephalopathy; Liver cirrhosis; Therapy

Indexed keywords

4 AMINOBUTYRIC ACID; AMMONIA;

CHRONIC LIVER DISEASE; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; EVOKED RESPONSE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; INFECTION; LABORATORY TEST; LIVER TRANSPLANTATION; METABOLIC DISORDER; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHIATRY; NEUROTRANSMISSION; PATHOGENESIS; PROGNOSIS; PROTEIN DIET; REVIEW; TREATMENT PLANNING;

CEREBRAL CORTEX; DIAGNOSTIC IMAGING; ELECTROENCEPHALOGRAPHY; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FUNCTION TESTS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS;

EID: 0347764722     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-003-1579-1     Document Type: Review

References (58)

1. Amodio P, Del Piccolo F, Marchetti P et al. (1999) Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 29(6):1662-1667
2. Amodio P, Marchetti P, Del Piccolo F et al. (1999) Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 110(8):1334-1344
3. Baktir G, Fisch HU, Karlaganis G (1987) Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiment with triazolam. Hepatology 7:629-638
4. Basile AS, Gammal SH, Mullen KD, Jones EA, Skolnick P (1988) Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepin receptor ligands in an animal model of hepatic encephalopathy. J Neurosci 8:2414-2421
5. Bergeron M, Reader TA, Pomier Layrargues G, Butterworth RF (1989) Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 14:853-859
6. Bernthal P, Hays A, Tarter RE, van Thiel D, Lecky J, Hegedus A (1987) Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 7:107-114
7. Bucci L, Palmieri GC (1993) Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy. Curr-Med Res Opin 13:109-118
8. Butterworth RF (1995) Detection of benzodiazepines in hepatic encephalopathy: reply. Hepatology 2:605
9. Butterworth RF (2000) Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol 32(1):171-180
10. Butterworth RF (2000) Hepatic encephalopathy: a neuropsychiatric disorder involving multiple neurotransmitter systems. Curr Opin Neurol 13(6):721-727
11. Cordoba J, Blei AT (1997) Treatment of hepatic encephalopathy. Am J Gastroent 92:1429-1439
12. DeWaele JP, Audet RM, Rose C, Butterworth RF (1997) The portocaval-shunted rat: a new model for the study of the mechanisms controlling voluntary methanol consumption and ethanol dependence. Alcohol Clin Exp Res 21:305-310
13. Ferenci P (1991) Hepatische Enzephalopathie Klinik der Gegenwart, Urban & Schwarzenberg, München Wien Baltimore
14. Ferenci P (2001) Hepatic encephalopathy. Dtsch Med Wochenschr 126 [Suppl 1]:76-80
15. Ferenci P, Herneth A, Steindl P (1996) Newer approaches to therapy of hepatic encephalopathy. Semin Liver Dis 16:329-338
16. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic Encephalopathy - Definition, Nomenclature, Diagnosis, and Quantification: Final Report of the Working Party at the 11th World Congress of Gastroenterology, Vienna 1998. Hepatology 35:716-721
17. Fischer JE, Baldessarini RJ (1971) False neurotransmitters and hepatic failure. Lancet 2(7715):75-80
18. Gabuzda Jr D, Philips GB, Davidson CS (1952) Reversible toxic manifestations in patients with cirrhosis of the liver given cation-exchange resins. N Engl J Med 246:124-130
19. Gerok W (1984) Hepatische Enzephalopathie. Therapie mit adaptierten Aminosäuren- und Ketosäurengemischen. Therapiewoche 34:49-62
20. Gerok W, Haeussinger D (1984) Ammonia detoxication and glutamine metabolism in severe liver disease and its role in the pathogenesis of hepatic encephalopathy. In: Haeussinger D, Sies H (eds) Glutamine Metabolism in Mammalian Tissues, Springer, Heidelberg Berlin New York Tokyo, pp. 257-277
21. Gyr K, Meier R, Haussler J, Bouletreau P, Fleig WE, Gatta A, Holstege A (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy. Gut 39:319-324
22. Haeussinger D (1990) Nitrogen metabolism in liver: structural-functional organization and physiological implications. Biochem J 267:281-290
23. Haeussinger D, Gerok W (1995) Rückwirkungen von Lebererkrankungen auf das Zentralnervensystem: Hepatogene Enzephalopathie. In: Gerok W, Blum HE (eds) Hepatologie, 2nd edn. Urban & Schwarzenberg, München Wien Baltimore pp 845-859
24. Haeussinger D, Steeb R, Gerok W (1992) Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenetic model and therapeutic implications. Clin Investig 70(5):411-415
25. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R (1997) Therapeutic efficacy of L-ornithine-Laspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double blind study. Hepatology 25:1351-1360
26. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H (1995) Manganese and chronic hepatic encephalopathy. Lancet 346(8970):270-274
27. Kullmann F, Hollerbach S, Holstege A, Scholmerich J (1995) Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol 22(1): 101-110
28. Lang F, Hauessinger D (1990) Interaction of Cell Volume and Cell Function. Springer, Berlin Heidelberg New York Tokyo
29. Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M (1997) Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 112(5):1610-1616
30. Lockwood AH (2002) Positron emission tomography in the study of hepatic encephalopathy. Metab Brain Dis 17(4):431-435
31. Lockwood AH, Murphy BW, Donnelly KZ, Mahl TC, Perini S (1993) Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 18(5): 1061-1068
32. Lockwood AH, Yap EW, Rhoades HM, Wong WH (1991) Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 11(2):331-336
33. Lockwood AH, Yap EW, Wong WH (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 11(2):337-341
34. Mendenhall CL, Rouster S, Marshall L, Weesner R (1986) A new therapy for portal systemic encephalopathy. American J Gastroent 81:540-543.
35. Morgan MY (1996) Noninvasive neuroinvestigation in liver disease. Semin Liver Dis 16(3):293-314
36. Naylor CD, O'Rourkee K, Detsky AS, Baker JP (1989) Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A Meta-Analysis. Gastroenterology 97:1033-1042
37. O'Carroll RE, Hayes PC, Ebmeier KP et al. (1991) Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 337(8752): 1250-1253
38. Plauth M, Egberts EH (1993) Was ist gesichert in der Therapie der hepatischen Enzephalopathie? Internist 34:35-42
39. Pomier Layrargues G (1996) TIPS and hepatic encephaloapthy. Semin Liver Dis 16:315-320
40. Pomier Layrargues G, Giguére JF, Lavoie J, Perney P, Gagnon S, D'Amour M (1994) Clinical efficacy of benzodiazepine antagonist RO 15-1788 (flumazenil) in cirrhotic patients with hepatic coma: results of a randomized double-blind placebo-controlled crossover trial. Hepatology 19:32-37
41. Pomier Layrargues G, Spahr L, Butterworth RF (1995) Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345:735
42. Pujol A, Pujol J, Graus F et al. (1993) Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 43(1):65-69
43. Ross B, Kreis R, Farrow NA, Ackermann Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19-27
44. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK (1994) Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunts: Results of a prospective controlled study. Hepatology 20:46-55
45. Schomerus H, Schreiegg J (1993) Prevalence of latent portosystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroent 31:231-234
46. Sterns RH, Riggs JE, Schochet SS Jr (1986) Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314(24):1535-1542
47. Strauss E, Tramote R, Silva EP, Caly WR, Honain NZ, Maffei RA, de Sa ME (1992) Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology 39:542-545
48. Sushma S, Dasarathy S, Tandon RK, Jain S, Gupta S, Bhist MS (1992) Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology 16:138-144
49. Tangermann A (1991) The role of mercaptans in the pathogenesis of hepatic encephalopathy. In: Bengtsson F, Jeppsson B, Almdal T, Vilstrup H (eds) Progress in Hepatic Encephalopathy and Metabolic Nitrogen Exchange, CRC Press, Boca Raton, pp 259-270
50. Tarao K, Ikeda T, Hayashi K, Sakurai A, Okada T, Ito T (1990) Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy. Gut 31:702-706
51. Taylor-Robinson SD, Sargentoni J et al.(1994) Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 20(5):1173-1178
52. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ (1994) Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 9(4):347-359
53. Taylor-Robinson SD, Sargentoni J et al.(1996) MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 11(3):249-268
54. Timmermann L, Gross J, Dirks M, Volkmann J, Freund HJ, Schnitzler A (2003) The cerebral oscillatory network of parkinsonian resting tremor. Brain 126(Pt 1):199-212
55. Weissenborn K, Ehrenheim C, Hori A, Kubicka S, Manns MP (1995) Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab Brain Dis 10(3): 219-231
56. Zeneroli ML, Cioni G, Vezzelli C, Grandi S, Crisi G, Luzietti R, Ventura E (1987) Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy. Evaluation by computed tomography. J Hepatol 4:283-292
57. Zieve FJ, Zieve L, Doizaki WM, Gilsdorf RB (1974) Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma. J Pharmacol Exp Ther 191(1):10-16
58. Zieve L, Doizaki WM, Zieve J (1974) Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 83(1): 16-28